V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209141 | 20077981 | 0 | 0 | Palliative (P) | 2019-05-04 | 2019-05-30 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101166303 |
| 20209149 | 20077982 | 1.71 | 61.6 | 03 | 2017-10-19 | 2017-10-27 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101216174 |
| 20209151 | 20077983 | 1.73 | null | Curative (C) | 2019-08-10 | 2019-09-01 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100691712 |
| 20209156 | 20077984 | 1.85 | 98 | Palliative (P) | null | 2016-10-03 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101463777 |
| 20209157 | 20077985 | 1.67 | 59.7 | Palliative (P) | 2018-03-20 | 2018-03-23 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100673058 |
| 20209159 | 20077986 | 1.66 | 85.3 | Palliative (P) | 2018-12-18 | 2019-01-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100352205 |
| 20209166 | 20077987 | 1.69 | null | Palliative (P) | 2017-03-31 | 2017-03-31 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100024009 |
| 20209170 | 20077988 | 0 | 0 | Curative (C) | 2019-07-26 | 2019-08-24 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100541406 |
| 20209173 | 20077989 | 1.72 | 79.05 | Neo-adjuvant (N) | 2019-02-27 | 2019-02-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101853588 |
| 20209174 | 20077990 | 1.74 | 54.5 | Neo-adjuvant (N) | 2017-02-01 | 2017-02-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100942485 |
| 20209178 | 20077991 | 1.52 | 127.6 | Curative (C) | 2019-10-10 | 2019-11-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101487740 |
| 20209179 | 20077992 | 0 | 0 | Palliative (P) | 2019-04-17 | 2019-05-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101503432 |
| 20209180 | 20077993 | 1.65 | 66.9 | Adjuvant (A) | 2019-11-15 | 2019-11-24 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100544115 |
| 20209184 | 20077994 | 1.7 | 93.6 | Neo-adjuvant (N) | 2019-05-18 | 2019-05-25 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101678048 |
| 20209187 | 20077995 | 1.79 | 63.1 | Curative (C) | 2019-03-17 | 2019-03-17 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100820131 |
| 20209192 | 20077996 | 1.65 | 94.9 | 03 | 2019-07-26 | 2019-08-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100304768 |
| 20209196 | 20077997 | 1.59 | 66.6 | Neo-adjuvant (N) | 2016-02-17 | 2016-03-10 | CAPECITABINE + CARBOPLATIN | null | Y | CAPECITABINE + CARBOPLATIN | 100072573 |
| 20209200 | 20077998 | 1.63 | 65.3 | Curative (C) | 2019-06-19 | 2019-07-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100697801 |
| 20209202 | 20077999 | 1.55 | 90.5 | Palliative (P) | 2022-03-02 | 2022-03-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101012999 |
| 20209204 | 20078000 | 1.65 | 62.9 | Palliative (P) | 2017-07-19 | 2017-07-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101225679 |
| 20209208 | 20078001 | 1.59 | 65.75 | Adjuvant (A) | null | 2017-06-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101682056 |
| 20209209 | 20078002 | 0 | 0 | Neo-adjuvant (N) | 2017-10-24 | 2017-11-14 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100404962 |
| 20209213 | 20078003 | 1.74 | 70.35 | Neo-adjuvant (N) | 2019-11-22 | 2019-12-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101411465 |
| 20209218 | 20078004 | 1.75 | 73.65 | null | 2017-04-20 | 2017-05-04 | CAPECITABINE + CARBOPLATIN | N | null | CISPLATIN + FLUOROURACIL | 101611987 |
| 20209222 | 20078005 | 1.72 | 78 | Palliative (P) | 2016-10-07 | 2016-10-23 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100563112 |
| 20209230 | 20078006 | 1.75 | 75.9 | Palliative (P) | 2020-04-22 | 2020-04-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100685285 |
| 20209237 | 20078007 | 1.8 | 103 | Curative (C) | 2018-05-13 | 2018-05-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101172451 |
| 20209240 | 20078008 | 1.58 | 41.7 | Palliative (P) | 2018-01-12 | 2018-01-12 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100323817 |
| 20209246 | 20078009 | 1.65 | 107.5 | Palliative (P) | null | 2017-07-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101788092 |
| 20209247 | 20078010 | 1.55 | 81.5 | Curative (C) | 2018-01-09 | 2018-02-02 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100491474 |
| 20209249 | 20078011 | 1.75 | 112 | null | 2020-04-10 | 2020-05-02 | CISPLATIN + FLUOROURACIL | 2 | null | CISPLATIN + FLUOROURACIL | 100644292 |
| 20209251 | 20078012 | 1.7 | 69.5 | Palliative (P) | 2018-09-09 | 2018-09-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100508065 |
| 20209253 | 20078013 | 0 | 0 | Curative (C) | 2019-10-23 | 2019-10-24 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100504117 |
| 20209255 | 20078014 | 1.61 | 113.6 | Curative (C) | 2016-08-17 | 2016-08-29 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 100482689 |
| 20209258 | 20078015 | 1.58 | 114.1 | Curative (C) | 2019-05-28 | 2019-05-29 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101225216 |
| 20209268 | 20078016 | null | null | Palliative (P) | 2021-09-04 | 2021-09-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101233197 |
| 20209269 | 20078017 | 1.5 | 76.1 | 03 | 2019-04-26 | 2019-04-26 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101231116 |
| 20209284 | 20078018 | 1.7 | 82.8 | Palliative (P) | 2017-08-15 | 2017-09-04 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101505822 |
| 20209293 | 20078019 | 1.75 | 81.6 | Curative (C) | 2017-12-18 | 2017-12-20 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN EMBOLISATION | 100511651 |
| 20209295 | 20078020 | 1.6 | 107.4 | Neo-adjuvant (N) | 2019-08-22 | 2019-09-02 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100907683 |
| 20209303 | 20078021 | 1.77 | 83.35 | Neo-adjuvant (N) | 2016-11-02 | 2016-11-02 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100709671 |
| 20209304 | 20078022 | 1.76 | 76.55 | Neo-adjuvant (N) | 2019-01-26 | 2019-01-26 | Capecitabine (21days) + Carboplatin | N | null | DOXORUBICIN EMBOLISATION | 100782407 |
| 20209307 | 20078023 | 1.78 | 79.79 | Palliative (P) | 2017-02-17 | 2017-03-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100203672 |
| 20209308 | 20078024 | null | 90.4 | Neo-adjuvant (N) | 2019-11-29 | 2019-11-30 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101782421 |
| 20209309 | 20078025 | 1.68 | 101 | Palliative (P) | 2018-03-22 | 2018-04-06 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101171182 |
| 20209312 | 20078026 | 1.48 | 68.9 | Palliative (P) | 2019-02-16 | 2019-02-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100393692 |
| 20209323 | 20078027 | 1.76 | 69.3 | Palliative (P) | 2016-12-18 | 2016-12-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101524834 |
| 20209329 | 20078028 | 1.75 | 40.2 | Neo-adjuvant (N) | 2016-08-06 | 2016-08-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101157050 |
| 20209343 | 20078029 | 0 | 0 | null | 2019-12-16 | 2020-01-06 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101051370 |
| 20209349 | 20078030 | 0 | 0 | Palliative (P) | 2014-09-18 | 2014-10-16 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101420227 |